MiCAN Technologies
Company Management

MiCAN Technologies

Biotechnology Research Kyoto, Hyôgo, Jp 9 employees
Employees
9
Contacts
2
Emails
2

MiCAN Technologies Overview

Headquarters
Kyoto, Hyôgo, Jp
Industry
Biotechnology Research
Employees
9
Founded
2016
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About MiCAN Technologies

A Kyoto University spinout company having production technologies to generate high performance artificial blood cells from stem cells. Their Mylc cell series are highly controlled immature dendritic cells suitable for evaluation of efficacy of drug discovery and safety assessment. Recently launched cMylc kit is exclusively designed for COVID-19 vaccines and drug development. The coronavirus optimised optimized myeloid lineage cells works as host cells with giving stable and robust performances for your research on COVID-19.

MiCAN Technologies Contact Details

People in AeroLeads
3
With contact data
2
Email contacts
2
66.7% coverage

MiCAN Technologies Org Chart

Sample employees and titles
Name Title Contact
Leticia Rika Isshiki Ramos
View
Takeshi Sakata Mican Technologies Inc.
Email
Kazuhisa Fushihara Mican Technologies Inc. - COO
Email

Employees by Management Level

Individual contributor 2 profiles
Executive 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 1 1 0

Compare Similar Companies to MiCAN Technologies